About

The plot of the submitted novel is highly credible, as it relates my knowledge and experience in healthcare, government, and the intelligence agencies.

I served as a tenured Professor in Radiation Oncology and Symptom Research at The University of Texas MD Anderson Cancer Center [MDACC]. I also served as Vice-Chair of the MDACC Institutional Review Board [IRB] for two decades. Clinical trial experience ranges from conducting, auditing and analyzing the outcomes from Phase I through Phase IV studies.

Based on my role at MDACC, I was appointed to the Medicare Evidence Development & Coverage Advisory Committee [MEDCAC] and the National Cancer Institute Central IRB, which approves and performs annual reviews on all national cooperative group trials. With a security clearance, I also served as a consultant to the U.S. Nuclear Regulatory Commission [NRC] and was sent to Vienna to compose a tecdoc for the International Atomic Energy Agency [IAEA]. Selected to author multiple Clinical Practice Guidelines for the Agency for Healthcare Research and Quality, American Society of Clinical Oncology [ASCO], National Comprehensive Cancer Network, National Quality Forum, American Society of Radiation Oncology [ASTRO], American College of Radiology [ACR], and the Institute for Clinical and Economic Review, I understand the process of medicine. I have also served in significant leadership roles in ASCO and ASTRO, and hold fellowships in the American College of Physicians, the ACR, ASTRO and ASCO. Most recently, I served as Chief Medical Officer [CMO] for a firm conducting Health Economics and Outcomes Research [HEOR] for major pharmaceutical firms.

With almost 200 peer-reviewed articles, serving as an editor for multiple medical journals and authoring over 60 medical textbook chapters, I have significant experience in the realm of medical publishing. While I understand that medical and literary publishing are very different, publishers share identical parameters for commercial success.

Other Works